Assessing Quality of Care for the Myelodysplastic Syndromes
|
Aug 2016
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Last Marrow Standing: Bone Marrow Transplantation for Acquired Bone Marrow Failure Conditions
|
Oct 2012
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times
|
Aug 2017
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
There's Risk, and Then There's RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes.
|
Aug 2013
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Molecular Testing in Patients with Suspected Myelodysplastic Syndromes
|
Oct 2016
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
|
Sep 2017
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Palliative and End-of-Life Care in Myelodysplastic Syndromes
|
Oct 2016
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Incidence and Burden of the Myelodysplastic Syndromes
|
Jul 2015
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Standardizing the Initial Evaluation for Myelodysplastic Syndromes.
|
Nov 2013
|
Curr Hematol
|
myelodysplastic syndromes (MDS)
|
Matched sibling donor hematopoietic stem cell transplant in patients with acquired aplastic anemia
|
Dec 2014
|
Curr Drug Targets
|
aplastic anemia
|